Skip to main content
. 2016 Jan 25;14:25. doi: 10.1186/s12967-016-0781-4

Fig. 3.

Fig. 3

Efficacy of i.p. CpG-ODN1826 (20 µg/mouse, qdx5d/wx4w) against orthotopic DMPM STO xenografts. a Orthotopic STO tumor weight distribution. Mice (six animals/group) were randomized to receive saline or CpG-ODN1826. The treatment started 4 days after cell injection (early-stage tumors). b Mice (ten animals/group) were randomized to receive saline or CpG-ODN1826. The treatment started 11 days after cell injection (late-stage tumors)